The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

sandstonedx.com

Executives

2

Board of Directors

5

Sandstone Diagnostics Board of Directors

5 Board of directors

Sandstone Diagnostics has 5 board of directors, including Faith Charles.

Name

Firm

Work History

Other Seats

Faith Charles

Faith has authored articles and presents on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs. She has been featured in Crain’s New York and profiled in The New York Times. She has earned recognition as a BTI Client Service All-Stars for service excellence, and from LMG Life Sciences for transactional and Life Sciences expertise. Faith is also on the board of several early stage companies. Faith has spoken for and served as a panelist and moderator for such organizations as Advamed, Springboard, and North Carolina Biotechnology Center. She has authored articles on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs.

Sandstone Diagnostics

Gary Altman

Dr. Altman is an investor, entrepreneur and leader of large and small scientific organizations. His experiences include senior management positions at Beckman Coulter, Sequoia Pharmaceuticals, and Sandstone Diagnostics as well as advisor to GE Healthcare, Terumo-CaridianBCT and GenVec among others. He earned a PhD in biochemistry/virology and held an NSF Post-Doctoral Fellowship in the BioPhysics and McArdle Laboratories at the University of Wisconsin, Madison.

Sandstone Diagnostics

Karen Drexler

Ms. Drexler brings technical / engineering capabilities, coupled with business vision and entrepreneurial experience, to the executive suite and the board room. She has been an active board member for public and private medical device and diagnostics companies for over a decade. She currently sits on the boards of ResMed (RSMD:NYSE), Outset Medical (Nasdaq: OM), Tivic Health, Bone Health Technologies, VIDA Diagnostics and EBR Systems. Ms. Drexler also has extensive management experience. She founded and ran Amira Medical until its sale to Roche Diabetes Care. She managed a variety of functions across the company at LifeScan and executed the sale of the company to Johnson & Johnson. Most recently, Ms. Drexler was the CEO of Sandstone Diagnostics, a life science tools company focused on increased access to high quality diagnostic testing. Ms. Drexler was named Female Entrepreneur of the Year by the Stevie Awards, 2013, and Entrepreneurial Woman of the Year by Silicon Valley Women’s Fund, 2002. She was also named a Director of the Year in 2018 by Women's Inc. Magazine. In addition to her corporate board roles, Ms. Drexler is active in Astia (www.astia.com) and Springboard (www.sb.co), nonprofit organizations that support female entrepreneurs. She is a Founding Member of Astia Angels. A Guest Lecturer at Stanford University in Medical Device Design and Mobile Health curriculums, Ms. Drexler also provides team support and mentoring for the Stanford Biodesign Fellowship and StartX, an off-campus Stanford Accelerator. A native of New Jersey, Ms. Drexler received her MBA from Stanford University and her BSE in Chemical Engineering from Princeton University. She and her husband Andy, a fellow Stanford MBA, reside in the San Francisco Bay Area.

Sandstone Diagnostics

Priya Balachandran

Sandstone Diagnostics

Sharon Vosmek

Sharon has held a number of senior finance roles within several sectors including marketing, manufacturing and IT

Sandstone Diagnostics

Name

Faith Charles

Gary Altman

Karen Drexler

Priya Balachandran

Sharon Vosmek

Firm

Work History

Faith has authored articles and presents on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs. She has been featured in Crain’s New York and profiled in The New York Times. She has earned recognition as a BTI Client Service All-Stars for service excellence, and from LMG Life Sciences for transactional and Life Sciences expertise. Faith is also on the board of several early stage companies. Faith has spoken for and served as a panelist and moderator for such organizations as Advamed, Springboard, and North Carolina Biotechnology Center. She has authored articles on topics including Alternative Financing Strategies, Strategic Collaborations and Biotech Entrepreneurs.

Dr. Altman is an investor, entrepreneur and leader of large and small scientific organizations. His experiences include senior management positions at Beckman Coulter, Sequoia Pharmaceuticals, and Sandstone Diagnostics as well as advisor to GE Healthcare, Terumo-CaridianBCT and GenVec among others. He earned a PhD in biochemistry/virology and held an NSF Post-Doctoral Fellowship in the BioPhysics and McArdle Laboratories at the University of Wisconsin, Madison.

Ms. Drexler brings technical / engineering capabilities, coupled with business vision and entrepreneurial experience, to the executive suite and the board room. She has been an active board member for public and private medical device and diagnostics companies for over a decade. She currently sits on the boards of ResMed (RSMD:NYSE), Outset Medical (Nasdaq: OM), Tivic Health, Bone Health Technologies, VIDA Diagnostics and EBR Systems. Ms. Drexler also has extensive management experience. She founded and ran Amira Medical until its sale to Roche Diabetes Care. She managed a variety of functions across the company at LifeScan and executed the sale of the company to Johnson & Johnson. Most recently, Ms. Drexler was the CEO of Sandstone Diagnostics, a life science tools company focused on increased access to high quality diagnostic testing. Ms. Drexler was named Female Entrepreneur of the Year by the Stevie Awards, 2013, and Entrepreneurial Woman of the Year by Silicon Valley Women’s Fund, 2002. She was also named a Director of the Year in 2018 by Women's Inc. Magazine. In addition to her corporate board roles, Ms. Drexler is active in Astia (www.astia.com) and Springboard (www.sb.co), nonprofit organizations that support female entrepreneurs. She is a Founding Member of Astia Angels. A Guest Lecturer at Stanford University in Medical Device Design and Mobile Health curriculums, Ms. Drexler also provides team support and mentoring for the Stanford Biodesign Fellowship and StartX, an off-campus Stanford Accelerator. A native of New Jersey, Ms. Drexler received her MBA from Stanford University and her BSE in Chemical Engineering from Princeton University. She and her husband Andy, a fellow Stanford MBA, reside in the San Francisco Bay Area.

Sharon has held a number of senior finance roles within several sectors including marketing, manufacturing and IT

Other Seats

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics

Sandstone Diagnostics Management Team

2 Team Members

Sandstone Diagnostics has 2 executives. Sandstone Diagnostics's current Chief Executive Officer is Gary G. Altman.

Name

Work History

Title

Status

Gary G. Altman

Chief Executive Officer

Current

Karen Drexler

Chief Executive Officer

Former

Name

Gary G. Altman

Karen Drexler

Work History

Title

Chief Executive Officer

Chief Executive Officer

Status

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.